Morgan Stanley’s Virtus LifeSci Biotech Clinical Trials ETF BBC Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $163K | Buy |
|
|||||
|
2025
Q1 | $148K | Sell |
|
|||||
|
2024
Q4 | $275K | Sell |
|
|||||
|
2024
Q3 | $368K | Sell |
|
|||||
|
2024
Q2 | $538K | Sell |
|
|||||
|
2024
Q1 | $1.17M | Buy |
|
|||||
|
2023
Q4 | $446K | Buy |
|
|||||
|
2023
Q3 | $128K | Buy |
|
|||||
|
2023
Q2 | $114K | Sell |
|
|||||
|
2023
Q1 | $123K | Sell |
|
|||||
|
2022
Q4 | $160K | Sell |
|
|||||
|
2022
Q3 | $169K | Sell |
|
|||||
|
2022
Q2 | $151K | Buy |
|
|||||
|
2022
Q1 | $188K | Sell |
|
|||||
|
2021
Q4 | $290K | Buy |
|
|||||
|
2021
Q3 | $312K | Sell |
|
|||||
|
2021
Q2 | $688K | Buy |
|
|||||
|
2021
Q1 | $654K | Buy |
|
|||||
|
2020
Q4 | $531K | Sell |
|
|||||
|
2020
Q3 | $556K | Sell |
|
|||||
|
2020
Q2 | $1.36M | Buy |
|
|||||
|
2020
Q1 | $556K | Buy |
|
|||||
|
2019
Q4 | $508K | Buy |
|
|||||
|
2019
Q3 | $214K | Buy |
|
|||||
|
2019
Q2 | $217K | Buy |
|
|||||
|
2019
Q1 | $147K | Buy |
|
|||||
|
2018
Q4 | $117K | Sell |
|
|||||
|
2018
Q3 | $357K | Sell |
|
|||||
|
2018
Q2 | $553K | Buy |
|
|||||
|
2018
Q1 | $89K | Buy |
|
|||||
|
2017
Q4 | $40K | Hold |
|
|||||
|
2017
Q3 | $41K | Hold |
|
|||||
|
2017
Q2 | $34K | Sell |
|
|||||
|
2017
Q1 | $34K | Sell |
|
|||||
|
2016
Q4 | $28K | Sell |
|
|||||
|
2016
Q3 | $90K | Buy |
|
|||||
|
2016
Q2 | $25K | Hold |
|
|||||
|
2016
Q1 | $26K | Sell |
|
|||||
|
2015
Q4 | $51K | Buy |
|
|||||
|
2015
Q3 | $36K | Buy |
|
|||||
|
2015
Q2 | $3K | Sell |
|
|||||
|
2015
Q1 | $5K | Buy |
|